ISIN | CH0269987423 |
---|---|
Valor Number | 26998742 |
Bloomberg Global ID | |
Fund Name | Bellevue Biotech CA CHF |
Fund Provider |
Bellevue Asset Management AG
Zürich, Switzerland Phone: +41 44 267 67 00 E-Mail: info@bellevue.ch Web: www.bellevue.ch |
Fund Provider | Bellevue Asset Management AG |
Representative in Switzerland | |
Distributor(s) |
Zürcher Kantonalbank Zürich Phone: +41 44 293 93 93 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | Special conditions apply to the issue of units |
Redemption Condition | Special conditions apply to the redemption of units |
Investment Strategy *** | N/A |
Peculiarities |
Current Price * | 100.10 CHF | 06.08.2025 |
---|---|---|
Previous Price * | 101.01 CHF | 05.08.2025 |
52 Week High * | 112.07 CHF | 11.11.2024 |
52 Week Low * | 86.97 CHF | 10.04.2025 |
NAV * | 100.10 CHF | 06.08.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 24,230,723 | |
Unit/Share Assets *** | 5,337,753 | |
Trading Information SIX |
YTD Performance | -3.35% |
31.12.2024 - 06.08.2025
31.12.2024 06.08.2025 |
---|---|---|
1 month | +6.13% |
07.07.2025 - 06.08.2025
07.07.2025 06.08.2025 |
3 months | +9.41% |
06.05.2025 - 06.08.2025
06.05.2025 06.08.2025 |
6 months | -9.71% |
06.02.2025 - 06.08.2025
06.02.2025 06.08.2025 |
1 year | +0.18% |
06.08.2024 - 06.08.2025
06.08.2024 06.08.2025 |
2 years | +7.25% |
07.08.2023 - 06.08.2025
07.08.2023 06.08.2025 |
3 years | -9.46% |
08.08.2022 - 06.08.2025
08.08.2022 06.08.2025 |
5 years | -4.79% |
06.08.2020 - 06.08.2025
06.08.2020 06.08.2025 |
Equity Participation Rate in % | 85.73 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Vertex Pharmaceuticals Inc | 8.88% | |
---|---|---|
Gilead Sciences Inc | 8.75% | |
Amgen Inc | 8.06% | |
Regeneron Pharmaceuticals Inc | 5.91% | |
Alnylam Pharmaceuticals Inc | 5.42% | |
AstraZeneca PLC ADR | 5.08% | |
Insmed Inc | 2.85% | |
Verona Pharma PLC ADR | 2.63% | |
BeOne Medicines Ltd ADR | 2.45% | |
Sandoz Group AG Registered Shares | 2.04% | |
Last data update | 30.06.2025 |
TER | 1.52% |
---|---|
TER date | 30.09.2024 |
Performance Fee *** | 10.00% |
PTR | |
Max. Management Fee *** | 1.80% |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** | 31.07.2025 |